Stay updated on JS002 Multiple-dose Safety and Efficacy in Hyperlipidemia Clinical Trial
Sign up to get notified when there's something new on the JS002 Multiple-dose Safety and Efficacy in Hyperlipidemia Clinical Trial page.

Latest updates to the JS002 Multiple-dose Safety and Efficacy in Hyperlipidemia Clinical Trial page
- Check4 days agoChange DetectedThe Record History now shows a new revision entry (v3.3.4) and excludes the previous v3.3.3 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded Revision: v3.3.3 to the Record History and removed HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check48 days agoChange DetectedA new revision entry v3.3.2 was added to the Record History, replacing v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedAdded Revision: v3.3.1 and removed Revision: v3.2.0 from the record history. This update concerns versioning metadata of the page and does not alter study details, status, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedThe government funding notice at the top of the page was removed.SummaryDifference0.8%

- Check76 days agoChange DetectedRecord History shows updates to core trial details across versions, including Recruitment Status, Study Status, Study Design, and Eligibility. The latest version includes changes to Outcomes and Contacts/Locations as well.SummaryDifference0.1%

Stay in the know with updates to JS002 Multiple-dose Safety and Efficacy in Hyperlipidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JS002 Multiple-dose Safety and Efficacy in Hyperlipidemia Clinical Trial page.